サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：医療用インプラントの世界市場-2023年～2030年
市場調査レポート
商品コード
1348008

医療用インプラントの世界市場-2023年～2030年

Global Medical Implants Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 181 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
医療用インプラントの世界市場-2023年～2030年
出版日: 2023年09月11日
発行: DataM Intelligence
ページ情報: 英文 181 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

医療用インプラントは、欠損した生物学的構造を補い、損傷した生物学的構造を支え、既存の生物学的構造を強化するために、体内または体表面に設置されます。その他の医療用インプラントは、薬物の送達、身体機能のモニター、臓器や組織のサポートに役立ちます。

医療用インプラントには、恒久的に埋め込むものと、一時的に埋め込むものがあります。例えば、ステントや股関節インプラントは永久的なものですが、化学療法ポートや骨折を修復するネジは、不要になったら取り外すことができます。インプラントの表面は、チタン、シリコーン、アパタイトなどの生体材料でできています。

さらに、技術進歩の増加、製品の発売、有利な償還政策などの重要な成長促進要因が、将来の市場成長をもたらします。Orthopedic Implant Company、Auxein Medical、Medtronic Plc、Stryker Corporationなどの主要企業が市場で積極的に活動しています。

ダイナミクス

医療用インプラントの製品上市の増加

医療用インプラントは、欠損した身体の一部を補うための人工器官として使用されます。大手企業による製品の上市は市場の成長を後押しし、こうした効果的な製品の上市は、研究の発見を新たな治療法に変え、何百万人もの人々のケアを改善するのに役立っています。

例えば、2023年2月、OSSIO, Inc.は新しいOSSIOfiber Compression Stapleを発売しました。OSSIOfiber圧縮ステープルは、OSSIOfiberインテリジェント骨再生技術で作られています。OSSIOfiberは、比類のない機械的強度と自然な骨治癒を非永久的なインプラントに組み合わせることで、永久的な金属製ハードウェアと従来の再吸収性インプラントおよび同種移植インプラントの欠点に対する初めての信頼できるソリューションを提供します。

さらに、2022年12月、アボット・ラボラトリーズは、Navitorと呼ばれる最新世代の経カテーテル大動脈弁植え込み（TAVI）システムを発売し、手術リスクが高いか極めて高い重症の大動脈弁狭窄症の患者にも低侵襲のデバイスを利用できるようにしました。したがって、上記の要因により、市場は予測期間中に拡大すると予想されます。

有利な償還政策が医療用インプラント市場を押し上げる

償還政策は、手技の複雑さ、使用されるインプラントの種類、手技中に利用される関連医療リソースなどの要因を考慮することが多いです。保険償還政策は、医療提供者がインプラント手術を行う際に提供される保険適用レベルや金銭的償還を決定するため、医療用インプラント市場において重要な役割を果たしています。

例えば、2023年3月、Inspire Medical Systems, Inc.は、ベルギーで国全体の償還承認を取得したと発表しました。この償還承認は、アントワープ大学病院（UZA）の指導の下、ベルギーにインスパイア移植センターを追加開設する道筋を提供するとともに、医療へのアクセスを拡大するものです。

さらに、2022年11月、エスタブリッシュメント・ラボ・ホールディングス・インクは、MotivaインプラントとMotiva Floraティッシュ・エキスパンダーが医薬品医療機器総合機構（PMDA）により日本での使用が承認されたことを発表し、これらの製品は日本の国民健康保険制度の下、乳房切除後の再建に対する償還も受けた。

歯科インプラントに伴う合併症が市場の成長を妨げる

歯科インプラントの合併症には、インプラントの周囲に骨が成長し、インプラントが勝手に抜け落ちてしまうオッセオインテグレーションがあります。歯科インプラントの主なリスクの一つは、上顎が鼻副鼻腔の直下にある副鼻腔損傷です。上の歯を補うために使用されるインプラントは、不快感や感染の可能性につながる副鼻腔に浸透する可能性があります。他のインプラントでも同様の事例があるため、市場成長の妨げになると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 医療用インプラントの製品上市の増加
      • 有利な償還政策
    • 抑制要因
      • 歯科インプラントに伴う合併症
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • アンメットニーズ
  • 規制分析
  • DMIの見解

第6章 COVID-19分析

第7章 製品別

  • 整形外科インプラント
    • 股関節インプラント
    • 人工関節インプラント
    • 脊椎インプラント
    • その他
  • 心血管インプラント
    • ペースメーカー
    • 植込み型除細動器（ICD）
    • 心臓ループレコーダー
  • 眼科インプラント
    • 三焦点レンズ
    • 焦点深度拡張型（EDOF）レンズインプラント
    • 単焦点レンズ
  • 歯科インプラント
    • 骨内インプラント
    • 骨膜下
  • 美容インプラント
    • 顔面インプラント
    • 乳房インプラント

第8章 材料タイプ別

  • セラミック
  • 金属
  • ポリマー
  • その他

第9章 エンドユーザー別

  • 病院
  • 整形外科センター
  • ASC（外来手術センター）
  • 心臓センター
  • フェイシャルエステセンター
  • 歯科病院
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 製品ベンチマーク
  • 企業シェア分析
  • 主な動向と戦略

第12章 企業プロファイル

  • Orthopedic Implant Company
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • Auxein Medical
  • Medtronic Plc.
  • Stryker Corporation
  • 4Web Medical
  • Smith & Nephew
  • Novel Biocare Services AG
  • Strauman AG
  • GS Medical
  • CurvaFix Inc.

第13章 付録

目次
Product Code: MD1907

Overview

Medical implants are placed inside or on the surface of the body to replace a missing biological structure, support a damaged biological structure, and enhance an existing biological structure. Other medical implants help in delivering medication, monitor body functions, and provide support to organs and tissues.

Medical implants can either be placed permanently or temporarily. For example, stents or hip implants are intended to be permanent but chemotherapy ports or screws to repair broken bones can be removed when they are no longer needed. The surface of implants is made of a biomedical material such as titanium, silicone, or apatite.

Furthermore, significant growth drivers such as increasing technological advancements, product launches, and favorable reimbursement policies give rise to future market growth. Significant key players like Orthopedic Implant Company, Auxein Medical, Medtronic Plc., Stryker Corporation, and others are actively operating in the market.

Dynamics

Increasing Product Launches for Medical Implants

Medical implants are used as prosthetics which are intended to replace missing body parts. The product launches by major companies help to drive market growth and these effective product launches help to transform research discoveries into new treatments and improve care for millions of people.

For instance, in February 2023, OSSIO, Inc. launched the new OSSIOfiber Compression Staple. OSSIOfiber Compression Staples are made with OSSIOfiber Intelligent Bone Regeneration Technology. OSSIOfiber provides the first credible solution to the shortcomings of permanent metal hardware and conventional resorbable and allograft implants by combining unparalleled mechanical strength and natural bone healing in a non-permanent implant.

Additionally, in December 2022, Abbott Laboratories launched its latest-generation transcatheter aortic valve implantation (TAVI) system called Navitor by making the minimally invasive device available for people with severe aortic stenosis who are at high or extreme surgical risk. Hence, due to the above factors, the market is expected to boost over the forecast period.

Favorable Reimbursement Policies are Boosting the Medical Implants Market

Reimbursement policies often consider factors such as the complexity of the procedure, the type of implant used, and the associated healthcare resources utilized during the procedure. Reimbursement policies play a crucial role in the medical implant market as they determine the level of coverage and financial reimbursement provided to healthcare providers for performing implantation procedures.

For instance, in March 2023, Inspire Medical Systems, Inc. stated that it has received countrywide reimbursement approval in Belgium, effective at rates consistent with other countries around the world. This reimbursement approval provides a pathway to open additional Inspire implanting centers in Belgium, under the guidance of Antwerp University Hospital (UZA) while also expanding access to care.

Additionally, in November 2022, Establishment Labs Holdings Inc. declared that Motiva Implants and the Motiva Flora tissue expander have been approved for use in Japan by the Pharmaceuticals and Medical Devices Agency (PMDA), and these products have also received reimbursement for post-mastectomy reconstruction under the Japanese National Health System.

Complications Associated with Dental Implants Will Hamper the Growth of the Market

Complications of dental implants include osseointegration where the bone grows around your implant and it can fall out on its own. One major dental implant risk is sinus damage where the upper jaw is directly under the nasal sinuses. Implants that are used to replace the top teeth can potentially penetrate into the sinus which leads to discomfort or possible infection. There are similar instances with other implants and thus these are expected to hamper the market growth.

Segment Analysis

The global medical implants market is segmented based on product, material type, end users, and region.

Orthopedic Implants is expected to hold the largest market share over the period forecast owing to increasing product launches. An orthopedic implant is a manufactured device designed to replace a joint, bone, or cartilage due to damage or deformity such as from breaking a leg, losing a limb, or a congenital defect.

For instance, in February 2023, CurvaFix, Inc. launched its smaller-diameter, 7.5mm CurvaFix IM Implant which is designed to simplify surgery and provide strong, stable fixation in small-boned patients. The company showcases the new 7.5mm intramedullary device, of which over two dozen have already been implanted in patients, at the American Academy of Orthopedic Surgeons (AAOS) 2023 Annual Meeting.

Additionally, in July 2023, The Orthopaedic Implant Company commercially launched of its innovative Threaded Metacarpal Nail System. The Threaded Metacarpal Nail System features a low insertion torque and minimally compressive design, ensuring optimal stability for various fracture patterns.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

The global medical implants market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa. North America has maintained a significant proportion of the medical implants market in recent years, and this trend is anticipated to continue throughout the forecast period due to factors such as the rising incidence of knee and hip replacements, and product launches in medical implants.

For instance, The American Joint Replacement Registry (AJRR), published its 2022 Annual Report on hip and knee arthroplasty procedural trends and patient outcomes. The annual report demonstrates an overall cumulative procedural volume growth of 14% compared to the previous year and includes over 2.8 million hip and knee procedures since 2012 from over 1,250 hospitals, ambulatory surgery centers (ASCs), and private practice groups. The number of procedures submitted by ASCs has grown exponentially between 2012 and 2020 and has increased by 57%.

Additionally, according to the Aesthetic Society, there were 365,000 breast implantations performed in 2021. In addition, 148,000 women had implants removed and replaced, and 71,000 had their implants removed and not replaced in the United States. Hence, the above factors help accelerate the region's growth.

Competitive Landscape

The major global players in the market include: Orthopedic Implant Company, Auxein Medical, Medtronic Plc., Stryker Corporation, 4Web Medical, Smith & Nephew, Novel Biocare Services AG, Strauman AG, GS Medical, CurvaFix Inc. among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the medical implants market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular check-ups, appointments, device implantations, and consultations worldwide. Many hospitals are focused on COVID-19 cases, and this reduced cardiac surgery in many patients suffering from chronic disease.

Moreover, the focus of research and development efforts shifted during the pandemic, with a significant emphasis on developing vaccines and treatments for COVID-19. Therefore, owing to the above factors, the medical implants market is expected to be moderately affected over the forecast period.

By Product

  • Orthopedic Implant
    • Hip Implants
    • Joint Replacement Implant
    • Spine Implant
    • Others
  • Cardiovascular Implants
    • Pacemakers
    • Implantable Cardioverter Defibrillator (ICD)
    • Cardiac Loop Recorders
  • Ophthalmic Implants
    • Trifocal lens
    • Extended-depth-of-focus (EDOF) lens implant
    • Monofocal lens implant
  • Dental Implants
    • Endosteal
    • Subperiosteal
  • Cosmetic Implants
    • Facial Implants
    • Breast Implants

By Material Type

  • Ceramic
  • Metallic
    • Titanium
    • Cobalt
    • Tantalum
    • Nickel
    • Others
  • Polymers
  • Others

By End Users

  • Hospitals
  • Orthopedic Centers
  • ASCs
  • Cardiac Centers
  • Facial Aesthetics Centers
  • Dental Hospitals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In December 2022, Abbott Laboratories received the U.S. Food and Drug Administration (FDA) approval of the company's Eterna spinal cord stimulation (SCS) system which is the smallest implantable, rechargeable spinal cord stimulator.
  • In Aug 2023, 4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technology launched the newest addition to the company's implant portfolio, the Cervical Spine Plating Solution (CSTS-PS).
  • In June 2023, Medics invested £1.8 million for clinical trials with the aim of precisely targeting heart patients who need tiny defibrillators to be fitted under their skin with the aim of reducing deaths from sudden cardiac arrests.

Why Purchase the Report?

  • To visualize the global medical implants market segmentation based on product, material type, end users, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global medical implants market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global medical implants market report would provide approximately 69 tables, 70 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Material Type
  • 3.3. Snippet by End Users
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Product Launches for Medical Implants
      • 4.1.1.2. Favorable Reimbursement Policies
    • 4.1.2. Restraints
      • 4.1.2.1. Complications Associated with Dental Implants
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Orthopedic Implant
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Hip Implants
    • 7.2.4. Joint Replacement Implant
    • 7.2.5. Spine Implant
    • 7.2.6. Others
  • 7.3. Cardiovascular Implants
    • 7.3.1. Pacemakers
    • 7.3.2. Implantable Cardioverter Defibrillator (ICD)
    • 7.3.3. Cardiac Loop Recorders
  • 7.4. Ophthalmic Implants
    • 7.4.1. Trifocal lens
    • 7.4.2. Extended-depth-of-focus (EDOF) lens implant
    • 7.4.3. Monofocal lens implant
  • 7.5. Dental Implants
    • 7.5.1. Endosteal
    • 7.5.2. Subperiosteal
  • 7.6. Cosmetic Implants
    • 7.6.1. Facial Implants
    • 7.6.2. Breast Implants

8. By Material Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 8.1.2. Market Attractiveness Index, By Material Type
  • 8.2. Ceramic
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Metallic
  • 8.4. Polymers
  • 8.5. Others

9. By End Users

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 9.1.2. Market Attractiveness Index, By End Users
  • 9.2. Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Orthopedic Centers
  • 9.4. ASCs
  • 9.5. Cardiac Centers
  • 9.6. Facial Aesthetics Centers
  • 9.7. Dental Hospitals
  • 9.8. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Product Benchmarking
  • 11.3. Company Share Analysis
  • 11.4. Key Developments and Strategies

12. Company Profiles

  • 12.1. Orthopedic Implant Company*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Auxein Medical
  • 12.3. Medtronic Plc.
  • 12.4. Stryker Corporation
  • 12.5. 4Web Medical
  • 12.6. Smith & Nephew
  • 12.7. Novel Biocare Services AG
  • 12.8. Strauman AG
  • 12.9. GS Medical
  • 12.10. CurvaFix Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us